There are a limited number of nanomaterials in development for feed additives, but projects with some momentum behind them include one looking to replace antibiotics with nano-sized substitutes, finds an EFSA-commissioned report.
A former FDA deputy commissioner for policy has denounced the
agency's capacity to properly regulate nanotechnology products
including supplements, a criticism that could inflame debate
leading up to the agency's first major...